Artemis Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.7M | Buy |
68,477
+6,304
| +10% | +$3.42M | 0.36% | 87 |
|
|
2025
Q4 | $36M | Buy |
62,173
+1,300
| +2% | +$735K | 0.44% | 82 |
|
|
2025
Q3 | $29.5M | Buy |
60,873
+22,071
| +57% | +$10.3M | 0.37% | 85 |
|
|
2025
Q2 | $15.7M | Sell |
38,802
-49,229
| -56% | -$20.6M | 0.2% | 133 |
|
|
2025
Q1 | $43.8M | Buy |
88,031
+72,971
| +485% | +$39.5M | 0.67% | 51 |
|
|
2024
Q4 | $7.83M | Sell |
15,060
-1,817
| -11% | -$999K | 0.11% | 153 |
|
|
2024
Q3 | $10.4M | Buy |
16,877
+8,566
| +103% | +$5.07M | 0.16% | 133 |
|
|
2024
Q2 | $4.6M | Sell |
8,311
-14,612
| -64% | -$8.37M | 0.06% | 167 |
|
|
2024
Q1 | $13.3M | Sell |
22,923
-45,230
| -66% | -$25.4M | 0.17% | 129 |
|
|
2023
Q4 | $36.2M | Sell |
68,153
-138,312
| -67% | -$66.9M | 0.52% | 62 |
|
|
2023
Q3 | $104M | Buy |
206,465
+70,220
| +52% | +$37.4M | 1.46% | 16 |
|
|
2023
Q2 | $71M | Sell |
136,245
-8,036
| -6% | -$4.34M | 0.89% | 31 |
|
|
2023
Q1 | $83M | Sell |
144,281
-31,927
| -18% | -$18M | 1.02% | 27 |
|
|
2022
Q4 | $97.5M | Sell |
176,208
-63,426
| -26% | -$33.6M | 1.1% | 29 |
|
|
2022
Q3 | $122M | Sell |
239,634
-100,228
| -29% | -$56.1M | 1.39% | 19 |
|
|
2022
Q2 | $185M | Buy |
339,862
+14,810
| +5% | +$8.15M | 1.9% | 6 |
|
|
2022
Q1 | $192M | Sell |
325,052
-75,732
| -19% | -$43.5M | 1.53% | 12 |
|
|
2021
Q4 | $267M | Sell |
400,784
-7,701
| -2% | -$4.81M | 1.94% | 8 |
|
|
2021
Q3 | $233M | Buy |
408,485
+118,938
| +41% | +$65.3M | 1.85% | 5 |
|
|
2021
Q2 | $146M | Buy |
289,547
+72,275
| +33% | +$34.1M | 1.26% | 14 |
|
|
2021
Q1 | $99.2M | Buy |
217,272
+32,961
| +18% | +$15.7M | 0.94% | 30 |
|
|
2020
Q4 | $85.9M | Sell |
184,311
-41,199
| -18% | -$19.3M | 0.9% | 29 |
|
|
2020
Q3 | $99.4M | Sell |
225,510
-27,220
| -11% | -$11.2M | 1.25% | 17 |
|
|
2020
Q2 | $91.7M | Buy |
252,730
+28,150
| +13% | +$9.44M | 1.23% | 19 |
|
|
2020
Q1 | $63.7K | Buy |
224,580
+129,508
| +136% | +$40.8M | 0.11% | 28 |
|
|
2019
Q4 | $30.8M | Buy |
95,072
+10,171
| +12% | +$3.08M | 0.39% | 83 |
|
|
2019
Q3 | $24.7M | Sell |
84,901
-3,930
| -4% | -$1.13M | 0.34% | 100 |
|
|
2019
Q2 | $26M | Sell |
88,831
-14,121
| -14% | -$3.89M | 0.31% | 100 |
|
|
2019
Q1 | $28.2M | Buy |
102,952
+568
| +0.6% | +$141K | 0.33% | 86 |
|
|
2018
Q4 | $22.9M | Sell |
102,384
-15,987
| -14% | -$3.75M | 0.3% | 100 |
|
|
2018
Q3 | $28.9M | Buy |
118,371
+6,729
| +6% | +$1.55M | 0.32% | 83 |
|
|
2018
Q2 | $23.1M | Buy |
111,642
+8,764
| +9% | +$1.86M | 0.32% | 83 |
|
|
2018
Q1 | $21.2M | Buy |
102,878
+4,883
| +5% | +$1.02M | 0.33% | 80 |
|
|
2017
Q4 | $18.6M | Buy |
97,995
+3,551
| +4% | +$680K | 0.31% | 82 |
|
|
2017
Q3 | $17.9M | Buy |
94,444
+546
| +0.6% | +$98.9K | 0.37% | 77 |
|
|
2017
Q2 | $16.4M | Sell |
93,898
-13,870
| -13% | -$2.33M | 0.4% | 62 |
|
|
2017
Q1 | $16.6M | Buy |
107,768
+14,695
| +16% | +$2.25M | 0.45% | 55 |
|
|
2016
Q4 | $13.1M | Sell |
93,073
-182
| -0.2% | -$26.8K | 0.35% | 71 |
|
|
2016
Q3 | $14.8M | Sell |
93,255
-13,990
| -13% | -$2.16M | 0.41% | 61 |
|
|
2016
Q2 | $15.8M | Sell |
107,245
-4,498
| -4% | -$664K | 0.43% | 65 |
|
|
2016
Q1 | $15.8M | Buy |
111,743
+24,302
| +28% | +$3.26M | 0.4% | 57 |
|
|
2015
Q4 | $12.4M | Buy |
87,441
+5,698
| +7% | +$760K | 0.31% | 78 |
|
|
2015
Q3 | $9.99M | Buy |
81,743
+857
| +1% | +$112K | 0.29% | 95 |
|
|
2015
Q2 | $10.5M | Buy |
80,886
+62,962
| +351% | +$8.21M | 0.34% | 69 |
|
|
2015
Q1 | $2.41M | Sell |
17,924
-78,607
| -81% | -$10.1M | 0.1% | 170 |
|
|
2014
Q4 | $12.1M | Buy |
96,531
+4,163
| +5% | +$506K | 0.47% | 59 |
|
|
2014
Q3 | $11.2M | Buy |
+92,368
| New | +$11.2M | 0.56% | 60 |
|
Other funds holding TMO
VCM
Artemis Investment Management's TMO Position: Q1 2026 in Review
Artemis Investment Management increased its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, buying an estimated $3.42M and bringing the position to 68,477 shares worth $33.7M. The position accounts for 0.36% of the portfolio, ranked #87.
Artemis Investment Management first reported a position in TMO in Q3 2014 and has held it in 47 quarters since. The position peaked at $267M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Artemis Investment Management held 68,477 shares of Thermo Fisher Scientific worth $33.7M as of Q1 2026.
- Artemis Investment Management bought 6,304 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.42M.
- Thermo Fisher Scientific made up 0.36% of Artemis Investment Management's portfolio in Q1 2026, its #87 holding.
- Artemis Investment Management first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 47 quarters since.
- Artemis Investment Management's Thermo Fisher Scientific position peaked at $267M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Artemis Investment Management's 13F filing for Q1 2026, filed 13 Apr 2026.